Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abbvie, abrocitinib, adult, agonistic, anti, Asbury, assay, Baird, baricitinib, barrier, benchmark, branebrutinib, cardiovascular, COBRA, Counsel, Cowen, crosstalk, culture, cultured, customary, cytometry, deeper, DSQ, durability, dysregulation, eczema, Eli, encourage, encouraging, EoDyssey, eos, epithelial, eruption, etrasimod, FceRI, flow, fostering, furniture, HD, hoc, home, hone, ID, IFNg, Incyte, infection, intermediate, JAKi, job, kill, KIT, KOL, landlord, lawsuit, leadership, leave, lebrikizumab, Lilly, LS, mAb, MACE, membrane, mental, microbiota, middle, mind, missed, MMRM, modest, molecular, motion, multicentered, murine, neuroinflammation, NME, notably, peace, plasma, PPE, proliferative, proton, PSU, pump, Radford, rarity, readout, rebounded, recoverable, red, reinforce, reorganization, repurpose, rescind, rescinded, rilzabrutinib, ruxolitinib, Sanofi, SCF, sensory, strongly, subcutaneously, tear, thereto, thrive, TNF, today, tralokinumab, turnover, underway, upadacitinib, vast, verified, virtually, week, workforce
Removed:
abated, administering, allergen, anatomic, ASU, BAL, bleomycin, bold, bronchoalveolar, bronchoconstriction, buffered, chemokine, choice, classify, collagen, combining, consultant, consumption, contractually, core, depleted, deposition, diseased, disorder, disposed, enactment, engrafted, estimating, existed, floor, formation, functionally, Gilead, induced, inducing, infiltrating, inhibited, Intermune, intestine, lavage, Leukocyte, lowered, lung, mouse, Nordisk, Novo, obstructive, ovalbumin, peaked, persisted, pharmacology, phosphate, practical, pretreated, proportionate, provisional, recognizing, remeasurement, rental, Replacement, retirement, saline, sensitized, stimulation, summarize, temperature, terminable, tool, Unaudited, unsensitized, weekly, wholly, ZS
Filing tables
Filing exhibits
Related press release
ALLK similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements:
(1)
Registration Statements (Form S-8 No. 333-226247, 333-231276, 333-236631, 333-253701, 333-262749) pertaining to the 2018 Equity Incentive Plan, the 2018 Employee Stock Purchase Plan and the amended 2012 Equity Incentive Plan of Allakos Inc., and
(2)
Registration Statement (Form S-3 No. 333-233018) of Allakos Inc.,
of our reports dated March 1, 2022, with respect to the financial statements of Allakos Inc. and the effectiveness of internal control over financial reporting of Allakos Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2021.
/s/ Ernst & Young LLP
Redwood City, California
March 1, 2022